We are live on ! Find out more
KA

Keene & Associates Portfolio holdings

AUM $125M
1-Year Est. Return 13.49%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
10 Year Est. Return
AUM
$134M
AUM Growth
+$13.4M
Cap. Flow
+$5.63M
Cap. Flow %
4.21%
Top 10 Hldgs %
30.08%
Holding
84
New
4
Increased
49
Reduced
18
Closed
2

Top Buys

Rank Stock Value
1
EVRG icon
Evergy
EVRG
+$3.32M
2
PFE icon
Pfizer
PFE
+$1.33M
3
NEM icon
Newmont
NEM
+$774K
4
B
Barrick Mining
B
+$644K
5
BMY icon
Bristol-Myers Squibb
BMY
+$572K

Sector Composition

Rank Sector Weight
1 Consumer Staples 19.33%
2 Healthcare 15.26%
3 Technology 15.03%
4 Materials 10.09%
5 Energy 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYNA icon
76
Synaptics
SYNA
$4.13B
$273K 0.2%
2,800
+215
+8% +$22.6K
SNN icon
77
Smith & Nephew
SNN
$13.5B
$262K 0.2%
10,340
+275
+3% +$7.55K
TMV icon
78
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$191M
$250K 0.19%
7,476
LFCR icon
79
Lifecore Biomedical
LFCR
$165M
$119K 0.09%
22,410
+475
+2% +$3.4K
NG icon
80
NovaGold Resources
NG
$2.61B
$30K 0.02%
10,000
NGD
81
DELISTED
New Gold Inc
NGD
$17K 0.01%
10,000
VGZ icon
82
Vista Gold
VGZ
$260M
$6.33K ﹤0.01%
11,200
OGN icon
83
Organon & Co
OGN
$3.56B
-74,623
Closed -$1.08M
VST icon
84
Vistra
VST
$52.6B
-13,305
Closed -$513K

Similar funds

Keene & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Keene & Associates held 84 positions worth $134M, up 11% from $120M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Keene & Associates deployed $5.63M of net new capital in Q1 2024, opening 4 new positions and adding to 49 existing holdings. Its largest new stake was Evergy: 64,935 shares worth $3.47M.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Intel, an estimated $1.01M trimmed.

  • Keene & Associates's largest Q1 2024 buy was Evergy: 64,935 shares worth $3.47M.
  • Keene & Associates added most to Pfizer in Q1 2024, an estimated $1.33M increase.
  • Keene & Associates's biggest Q1 2024 reduction was Intel, cutting an estimated $1.01M.
  • Keene & Associates fully exited Organon & Co in Q1 2024, selling an estimated $1.08M.
  • Keene & Associates's ten largest holdings make up 30% of its $134M portfolio in Q1 2024.
  • Keene & Associates opened 4 new positions and closed 2 in Q1 2024.
  • Keene & Associates's portfolio value rose 11% quarter-over-quarter to $134M.

Based on Keene & Associates's 13F filing for Q1 2024, filed 24 Apr 2024.